awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42344607-2C26B6F5-C82B-4C38-9033-3F832D65A30A
Q42344607-2C26B6F5-C82B-4C38-9033-3F832D65A30A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42344607-2C26B6F5-C82B-4C38-9033-3F832D65A30A
New immunotherapeutic paradigms for castration-resistant prostate cancer.
P2860
Q42344607-2C26B6F5-C82B-4C38-9033-3F832D65A30A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42344607-2C26B6F5-C82B-4C38-9033-3F832D65A30A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4445f555c03bb8a27225d18b0e8d1868b05def5
P2860
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial